Anna Becker studied Clinical Psychology and Neuroscience at the University of Basel. As a student assistant, she helped investigating the neuro-cognitive underpinnings of judgment and decision processes in people with schizophrenia as well as dopaminergic influences on (EEG) resting-state connectivity in people with psychotic disorders. Since 2020 she has been a PhD Candidate in the psychopharmacology research group of Prof. Matthias Liechti at the University Hospital Basel where she investigates the role of 5-HT2A receptor down-regulation and antagonism in the acute effects of psilocybin and LSD. In this function, she has accompanied over 80 psychedelic experiences from healthy test subjects. She is interested in the basic physiological processes of psychoactive substances as well as their psychotherapeutic applications.